Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Determinants of Bacterial Pathogenicity and Virulence01:20

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Special Staining Techniques01:13

Special Staining Techniques

Specialized staining techniques play a vital role in microbiology by enabling the visualization of specific bacterial structures that remain undetectable with standard microscopy methods. These techniques not only enhance the structural visualization of bacterial cells but also provide critical insights into their pathogenicity and classification. Additionally, they support diagnostic and research endeavors in microbiology by identifying key bacterial features.Capsule Staining for Virulence...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chemotherapy of experimental melioidosis in mice.

Antibiotics & chemotherapy (Northfield, Ill.)·2014
Same author

Hemolytic Streptococcal Pneumonia and Empyema: A Study of 55 Cases with Special Reference to Treatment.

Transactions of the American Clinical and Climatological Association·2011
Same author

A study of a food-borne epidemic of tonsilitis and pharyngitis due to beta-hemolytic streptococcus, type 5.

Bulletin of the Johns Hopkins Hospital·2010
Same author

Factors determining the dosage of penicillin in the treatment of infections.

Bulletin of the New York Academy of Medicine·2010
Same author

Fibrinolysin production by beta-hemolytic streptococci.

The American journal of medicine·2010
Same author

A study of infectious diseases in families.

Bulletin - Academy of Medicine of Cleveland·2010
Same journal

Retraction: In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation.

The Journal of experimental medicine·2026
Same journal

Intravesical mesothelin-based CAR T cells targeting MUC16 effectively control bladder cancer in preclinical models.

The Journal of experimental medicine·2026
Same journal

Flawed translation triggers oncogenic B-T cell communication.

The Journal of experimental medicine·2026
Same journal

Correction: LCK'ed in: Inborn errors of immunity in LCK reveal how TCR signaling is calibrated.

The Journal of experimental medicine·2026
Same journal

Mechanobiology of inflammation: Pulling the strings of innate immunity.

The Journal of experimental medicine·2026
Same journal

Bile acid retention in efferocytic macrophages shapes their inflammatory status during cholangitis.

The Journal of experimental medicine·2026
See all related articles

Related Experiment Video

Updated: Jun 19, 2026

A Fluorescence-based Method to Study Bacterial Gene Regulation in Infected Tissues
07:10

A Fluorescence-based Method to Study Bacterial Gene Regulation in Infected Tissues

Published on: February 19, 2019

SPECIFIC COAGULASES OF STAPHYLOCOCCUS AUREUS.

C H Rammelkamp1, M M Hezebicks, J H Dingle

  • 1Departments of Preventive Medicine and of Medicine, School of Medicine, Western Reserve University, and the University Hospitals, Cleveland.

The Journal of Experimental Medicine
|October 30, 2009
PubMed
Summary
This summary is machine-generated.

Researchers differentiated three staphylococcal coagulases (I, II, and III) using human antibody titers. Coagulase III showed relation to both I and II, impacting staphylococcal infection studies and anticoagulase antibody research.

More Related Videos

Quantifying the Cytotoxicity of Staphylococcus aureus Against Human Polymorphonuclear Leukocytes
12:27

Quantifying the Cytotoxicity of Staphylococcus aureus Against Human Polymorphonuclear Leukocytes

Published on: January 3, 2020

Related Experiment Videos

Last Updated: Jun 19, 2026

A Fluorescence-based Method to Study Bacterial Gene Regulation in Infected Tissues
07:10

A Fluorescence-based Method to Study Bacterial Gene Regulation in Infected Tissues

Published on: February 19, 2019

Quantifying the Cytotoxicity of Staphylococcus aureus Against Human Polymorphonuclear Leukocytes
12:27

Quantifying the Cytotoxicity of Staphylococcus aureus Against Human Polymorphonuclear Leukocytes

Published on: January 3, 2020

Area of Science:

  • Microbiology and Immunology
  • Bacterial Pathogenesis
  • Staphylococcal Research

Background:

  • Staphylococcal coagulase is a key virulence factor in staphylococcal infections.
  • Understanding coagulase types is crucial for accurate pathogenesis studies.
  • Previous research has not fully elucidated the antigenic relationships between different coagulase types.

Purpose of the Study:

  • To differentiate between three types of staphylococcal coagulases (I, II, and III).
  • To investigate the antigenic relationships among coagulase types I, II, and III.
  • To highlight the importance of using correct coagulase types in staphylococcal infection research.

Main Methods:

  • Measurement of antibody titers in human sera against different coagulase types.
  • Specific neutralization experiments to confirm antigenic distinctions and relationships.
  • Preliminary animal studies to observe anticoagulase development post-infection.

Main Results:

  • Staphylococcal coagulases I and II were found to be antigenically distinct.
  • Coagulase III exhibited antigenic relationships with both coagulase I and coagulase II.
  • Specific neutralization experiments validated these antigenic findings.

Conclusions:

  • The antigenic heterogeneity of staphylococcal coagulases necessitates the use of specific types in pathogenesis research.
  • Coagulase III's shared antigenic properties suggest a complex relationship within staphylococcal species.
  • The development of specific anticoagulase antibodies in infected animals indicates a potential role in recovery, which requires further investigation.